Intas Pharmaceuticals Limited Simvastatin Export Data — India (DGFT 2022–2026)

Name: Intas Pharmaceuticals Limited Simvastatin Export Records India — #9 Exporter, 238 Shipments, $2.4M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-04-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Simvastatin

India Pharmaceutical Trade Intelligence

$125.9M150 Suppliers84 CountriesHS 30049099

ExportsIndia → UNITED STATES29.0%India → HUNGARY21.3%

ImportsCANADA → India$8.8M MALTA → India$3.0M

#1 Supplier: MYLAN LABORATORIES #1 Buyer: MYLAN HUNGARY

Intas Pharmaceuticals Limited — Simvastatin Exporter #9 | $2.4M Trade Value | TransData Nexus | TransData Nexus

Intas Pharmaceuticals Limited — Simvastatin Exporter Profile

Indian Pharmaceutical Exporter · #9 for Simvastatin · $2.4M export value · DGFT Verified

Intas Pharmaceuticals Limited is the #9 Indian exporter of Simvastatin with $2.4M in export value and 238 verified shipments. Intas Pharmaceuticals Limited holds a 1.9% market share in Simvastatin exports across 6 countries. The company exports 75 pharmaceutical products worth $372.3M across 19 therapeutic categories.

Intas Pharmaceuticals Limited — Simvastatin Export Profile: Buyers & Destinations

Intas Pharmaceuticals Limited Simvastatin export treemap — buyers and destination countries | TransData Nexus

Where Does Intas Pharmaceuticals Limited Export Simvastatin?

Country	Value	Shipments	Share
UNITED KINGDOM	$1.4M	104	66.5%
NETHERLANDS	$401.5K	54	19.2%
SURINAME	$133.5K	3	6.4%
ITALY	$112.6K	68	5.4%
JAMAICA	$44.0K	8

Who Are the Top Buyers of Simvastatin from Intas Pharmaceuticals Limited?

Buyer	Country	Value	Orders
FAWDON MANUFACTURING CENTRE ( SF )	UNITED KINGDOM	$839.3K	47
ACCORD UK	UNITED KINGDOM	$353.3K	38
BROCACEF NL DUTCH	NETHERLANDS	$155.7K	8
FAWDON MANUFACTURING CENTRE (SF)	UNITED KINGDOM	$139.9K	4
BROCACEF NL : DUTCH	NETHERLANDS	$135.6K	14
LABANALYSIS S.R.L	ITALY	$112.6K	45
TO THE ORDER	UNITED KINGDOM	$106.5K	6
TO THE ORDER ..,	SURINAME	$83.5K	2
BROCACEF NL:DUTCH	NETHERLANDS	$46.9K	1
ALLOGA FRANCE	NETHERLANDS	$35.9K	29

Intas Pharmaceuticals Limited supplies Simvastatin to 24 buyers globally. The largest buyer is FAWDON MANUFACTURING CENTRE ( SF ) (UNITED KINGDOM), followed by ACCORD UK (UNITED KINGDOM) and BROCACEF NL DUTCH (NETHERLANDS). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Simvastatin Formulations Does Intas Pharmaceuticals Limited Export?

Product Description / Formulation	Value	Shipments
PHARMA DRUGS & MEDI SIMVASTATIN 40MG 13000T TLB(ACO-EUROPE AS PER INVOICE	$485.4K	25
PHARMA DRUGS & MEDI SIMVASTATIN 20MG 26000T TLB(ACO-EUROPE AS PER INVOICENOS	$168.5K	9
PHARMA DRUG&MED:SIMVASTATIN 40MG 13000T	$167.1K	6
PHARMA DRUGS & MEDI SIMVASTATIN 40MG 13000T TLB(ACO-EUROPE AS PER INVOICENOS	$105.4K	9
PHARMA DRUGS & MEDI SIMVASTATIN 40MG 500T HDPE(ACCORD-NL AS PER INVOICE	$90.3K	5
PHARMA DRUGS AND MEDICINE-SIMVASTATIN 20MG 2X15T(DUTCH)Each film coated tablet contains Simvastatin Ph.QTY-94500X2X15TAB	$83.5K	2
PHARMA DRUG&MED:SIMVASTATIN 40MG 6X15T	$59.2K	3
PH.DRU. & MED.: SIMVASTATIN 20MG TABLETS(SIMVASTATIN TABLETS 20MG EACH TABLETSCONT. SIMVASTATIN PH. EUR. 20MG) [0.19X1	$50.0K	1
PH.DRU. & MED.: SIMVASTATIN 40MG TABLETS(SIMVASTATIN TABLETS 40MG EACH TABLETSCONT. SIMVASTATIN PH. EUR. 40MG) [0.31X1	$50.0K	1
PHARMA DRUGS & MEDI: SIMVASTATIN 40MG 2X15T (DUTCH)(72336X2X15TAB)	$50.0K	1

Intas Pharmaceuticals Limited exports 97 distinct Simvastatin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is PHARMA DRUGS & MEDI SIMVASTATIN 40MG 13000T TLB(ACO-EUROPE A with 25 shipments worth $485.4K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.

How Does Intas Pharmaceuticals Limited Compare to Nearest Simvastatin Exporters?

Exporters ranked immediately above and below #9 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
3	IPCA LABORATORIES LIMITED	$3.9M	77	6	$50.0K
7	AUROBINDO PHARMA LIMITED	$3.3M	180	8	$18.4K
9	INTAS PHARMACEUTICALS LIMITED ★	$2.4M	238	6	$10.0K
10	TORRENT PHARMACEUTICALS LTD	$2.3M	97	8	$24.1K
12	MEPRO PHARMACEUTICALS PRIVATE LIMITED	$2.0M	40	5	$49.7K

Intas Pharmaceuticals Limited ranks #9 among 150 Indian Simvastatin exporters. Average shipment value of $10.0K compared to the market average of $538.9K. The closest competitors by value are IPCA LABORATORIES LIMITED and AUROBINDO PHARMA LIMITED.

Which Indian Ports Ship Simvastatin Exports?

Port	Shipments	% Share
NHAVA SHEVA SEA (INNSA1)	422	10.9%
SAHAR AIR CARGO ACC (INBOM4)	301	7.8%
SAHAR AIR	240	6.2%
JNPT/ NHAVA SHEVA SEA	228	5.9%
DELHI AIR	216	5.6%
DELHI AIR CARGO ACC (INDEL4)	202	5.2%
VIZAG SEA	177	4.6%
MUNDRA SEA	150	3.9%

Geopolitical & Trade Policy Impact on Intas Pharmaceuticals Limited's Simvastatin Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Intas Pharmaceuticals. The Israel-Iran tensions have led to increased security risks in the Strait of Hormuz and the Red Sea–Suez Canal corridor, prompting major carriers to reroute shipments around the Cape of Good Hope. This detour has extended transit times by 10–20 days and raised freight rates by 40–50% on key India–Europe routes, impacting the cost-effectiveness and timeliness of exports. (livemint.com)

Conversely, the ongoing US-China trade tensions have opened avenues for Indian pharmaceutical companies to capture a larger share of the U.S. market. Intas's acquisition of UDENYCA® and the FDA's acceptance of its biosimilar applications position the company to leverage these opportunities effectively. However, compliance with the European Union's Falsified Medicines Directive (FMD) remains a critical factor for market access. Intas's proactive approach in securing partnerships and ensuring regulatory compliance underscores its commitment to maintaining and expanding its presence in the European market.

Intas Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

Maintaining stringent regulatory compliance is paramount for Indian pharmaceutical exporters. Intas Pharmaceuticals has demonstrated a strong commitment to adhering to international quality standards, as evidenced by its successful acquisitions and partnerships that necessitate compliance with FDA, WHO, and EU Good Manufacturing Practices (GMP). The company's proactive engagement in regulatory processes, such as the FDA's acceptance of its Biologics License Application for DMB-3115, reflects its dedication to quality and compliance. (intaspharma.com) As global regulatory requirements continue to evolve, Intas's focus on quality assurance and compliance positions it favorably in the competitive pharmaceutical export market.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Simvastatin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Intas Pharmaceuticals Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 243 individual customs records matching Intas Pharmaceuticals Limited exporting Simvastatin, covering 97 formulations to 6 countries via 24 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 84+ countries, 421+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Simvastatin

Simvastatin

Intas Pharmaceuticals Limited — Simvastatin Exporter Profile

Intas Pharmaceuticals Limited — Simvastatin Export Profile: Buyers & Destinations

Where Does Intas Pharmaceuticals Limited Export Simvastatin?

Who Are the Top Buyers of Simvastatin from Intas Pharmaceuticals Limited?

What Is India's Total Simvastatin Export Value and How Much Does Intas Pharmaceuticals Limited Contribute?

What Is the Average Shipment Value for Intas Pharmaceuticals Limited's Simvastatin Exports?

How Does Intas Pharmaceuticals Limited Compare to Other Indian Simvastatin Exporters?

What Simvastatin Formulations Does Intas Pharmaceuticals Limited Export?

Regulatory Requirements: Exporting Simvastatin to Key Markets

United Kingdom — MHRA

How Does Intas Pharmaceuticals Limited Compare to Nearest Simvastatin Exporters?

Which Indian Ports Ship Simvastatin Exports?

Geopolitical & Trade Policy Impact on Intas Pharmaceuticals Limited's Simvastatin Exports

Intas Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

About Intas Pharmaceuticals Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Simvastatin Export Data from Intas Pharmaceuticals Limited

Simvastatin Stats

Company Overview

Top Products by Intas Pharmaceuticals Limited

Related Analysis

Need Detailed Export Data?

Data Source